Aytu Biopharma (AYTU) Current Deferred Tax Assets (2015)

Aytu Biopharma (AYTU) posted quarterly Current Deferred Tax Assets of $94211.0 for Q3 2015, up 127.41% quarter-over-quarter from $41427.0 in Q2 2015.

Aytu Biopharma (AYTU) Current Deferred Tax Assets (2015) Analysis & Trends

Aytu Biopharma (AYTU) has reported Current Deferred Tax Assets for 1 consecutive years, with $94211.0 the latest figure, recorded in Q3 2015.

In Q3 2015, Current Deferred Tax Assets changed N/A year-over-year to $94211.0; the TTM figure through Sep 2015 stood at $94211.0 (changed N/A YoY), while the FY2015 annual figure was $41427.0, up 29.46% from the prior year.
Current Deferred Tax Assets grew to $94211.0 in Q3 2015 per AYTU's latest filing, from $41427.0 in the prior quarter.
Across five years, Current Deferred Tax Assets topped out at $94211.0 in Q3 2015 and bottomed at $41427.0 in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-
10	Aytu Biopharma	24.81 Mn	-1.91 Mn	7.60 Mn

Download Data